HK1078471A1 - Improvements in or relating to immune functions - Google Patents

Improvements in or relating to immune functions

Info

Publication number
HK1078471A1
HK1078471A1 HK05110419.7A HK05110419A HK1078471A1 HK 1078471 A1 HK1078471 A1 HK 1078471A1 HK 05110419 A HK05110419 A HK 05110419A HK 1078471 A1 HK1078471 A1 HK 1078471A1
Authority
HK
Hong Kong
Prior art keywords
relating
immune functions
dose
diindolymethane
chrysin
Prior art date
Application number
HK05110419.7A
Other languages
English (en)
Inventor
Michael Donald Farley
Original Assignee
Michael Donald Farley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael Donald Farley filed Critical Michael Donald Farley
Publication of HK1078471A1 publication Critical patent/HK1078471A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK05110419.7A 2003-01-09 2005-11-18 Improvements in or relating to immune functions HK1078471A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/000709 WO2004062683A1 (en) 2003-01-09 2003-01-09 Improvements in or relating to immune functions

Publications (1)

Publication Number Publication Date
HK1078471A1 true HK1078471A1 (en) 2006-03-17

Family

ID=34885486

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05110419.7A HK1078471A1 (en) 2003-01-09 2005-11-18 Improvements in or relating to immune functions

Country Status (8)

Country Link
EP (1) EP1581238B1 (xx)
JP (1) JP2006501308A (xx)
CN (1) CN100579535C (xx)
AT (1) ATE395925T1 (xx)
DE (1) DE60321227D1 (xx)
HK (1) HK1078471A1 (xx)
MX (1) MXPA04011768A (xx)
WO (1) WO2004062683A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697670B2 (en) * 2009-01-28 2014-04-15 Life Science Nutrition As Compositions and methods of treating viral infections
ES2428665B1 (es) * 2012-05-04 2014-10-01 Universidad De Valladolid Composición para su uso en el tratamiento y/o prevención de la inflamación, el estrés oxidativo y la neovascularización ocular
CN106974904B (zh) * 2017-03-14 2020-07-28 南方医科大学 杨梅素及其衍生物的新用途和一种抗hiv感染的杀微生物剂
CN110772578A (zh) * 2019-11-11 2020-02-11 李胜 一种用于癌症防治的人体免疫力增强剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU689036B2 (en) * 1995-05-10 1998-03-19 Kureha Chemical Industry Co., Ltd. Pharmaceutical composition containing substance inhibiting HSP47 production
US6238673B1 (en) * 1996-09-20 2001-05-29 The Howard Foundation Method of producing high flavonol content polyphenol compositions
AU4310697A (en) * 1996-09-20 1998-04-14 Howard Foundation, The Method of producing polyphenol-containing compositions
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US20020192310A1 (en) * 2001-02-02 2002-12-19 Bland Jeffrey S. Medical composition for managing hormone balance

Also Published As

Publication number Publication date
WO2004062683A1 (en) 2004-07-29
EP1581238B1 (en) 2008-05-21
JP2006501308A (ja) 2006-01-12
MXPA04011768A (es) 2005-03-31
CN1638786A (zh) 2005-07-13
DE60321227D1 (de) 2008-07-03
ATE395925T1 (de) 2008-06-15
CN100579535C (zh) 2010-01-13
EP1581238A1 (en) 2005-10-05

Similar Documents

Publication Publication Date Title
US6544564B1 (en) Cytotoxic pharmaceutical composition
MXPA04003666A (es) Uso de flibanserina para tratamiento de trastornos sexuales.
AP1872A (en) Virus-like particles of human papillomavirus.
IL192137A (en) Formulations useful in the treatment of male and female impotence
HUP0401534A2 (hu) Módosított humán IX. faktor
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
ATE314095T1 (de) Virusähnliche partikel zur induktion von autoantikörpern
HK1068149A1 (en) Dedifferentiated, programmable stem cells of monocytic origin, and their production and use.
TNSN07290A1 (en) Gastroresistant pharmaceutical formulations containing rifaximin
AU2002316820A1 (en) Powder inhaler formulations
BE2011C013I2 (xx)
US6767563B2 (en) Immune functions
HK1078471A1 (en) Improvements in or relating to immune functions
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
EP1510217A4 (en) Antirrhumate and method for its production
CA2334520A1 (en) Treatment of immune diseases
WO2002098442A3 (de) Phytasehaltige zusammensetzung
AP2001002369A0 (en) Pharmaceutical complex.
WO2005023240A3 (de) Pharmazeutisches kombinationspräparat, enthaltend glycyrrhizinsäure, zink und eine verbindung, die eine thiolgruppe oder eine zu dieser metabolisierbare gruppe enthält
HK1075390A1 (en) Citalopram for the treatment of elevated blood pressure
ATE261732T1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
MD1473G2 (ro) Remediu antiherpetic
WO2006128679A3 (en) Phosphatidylinositol composition and 3'-phosphorylated lysophosphatidylinositols in the treatment of cancer and autoimmune diseases
MD2788F1 (en) Entomologic anti-inflammatory and antioxidant preparation

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140109